TipRanks
Apyx Medical Corporation (DE:BOV)
FRANKFURT:BOV
Germany Market

Apyx Medical (BOV) Blogger Opinions & Sentiment

1 Followers

Blogger Sentiment

Bearish: 100.00%
Sector Average
Bearish
DE:BOV Blogger sentiment is based on 2 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
50% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Apyx Medical: Negative Cash Flow And High Valuation
SeekingAlpha
Is Apyx Medical Corp (APYX) Significantly Overvalued After Q2 Earnings Beat? EPS: -0.08, Revenue: $13.9M -- GF Score: 63/100
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of DE:BOV?
Seeking Alpha’s Sorrento Research has a Bearish Sentiment.
    What do Motley Fool contributors think of DE:BOV?
    Currently there's no blogger sentiment for DE:BOV.
    What Is DE:BOV’s Blogger Sentiment?
    DE:BOV’s Blogger Sentiment is Bearish.
      What was the most recent blogger prediction for DE:BOV?
      The most recent blogger prediction for DE:BOV was made by Sorrento Research, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          ABTAbbott Laboratories
          PGENPrecigen
          DRTSAlpha Tau
          AXSMAxsome Therapeutics
          CALZFPolynovo